Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Total Inventories : ¥237 Mil (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Total Inventories?

Zhongyuan Union Cell & Gene Engineering's total inventories for the quarter that ended in Mar. 2025 was ¥237 Mil. Zhongyuan Union Cell & Gene Engineering's average total inventories from the quarter that ended in Dec. 2024 to the quarter that ended in Mar. 2025 was ¥235 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Zhongyuan Union Cell & Gene Engineering's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ¥1.06.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Zhongyuan Union Cell & Gene Engineering's Days Inventory for the three months ended in Mar. 2025 was 192.54.

Inventory Turnover measures how fast the company turns over its inventory within a year. Zhongyuan Union Cell & Gene Engineering's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zhongyuan Union Cell & Gene Engineering's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.67.

Zhongyuan Union Cell & Gene Engineering Total Inventories Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Total Inventories Chart

Zhongyuan Union Cell & Gene Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

222.40

226.96

248.09

247.90

232.19

Zhongyuan Union Cell & Gene Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Inventories	Get a 7-Day Free Trial															259.13	262.18	264.99	232.19	236.84

Zhongyuan Union Cell & Gene Engineering Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Zhongyuan Union Cell & Gene Engineering's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is

	Net-Net Working Capital Per Share (Q: Mar. 2025 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1551.412	+	0.75 * 605.066	+	0.5 * 236.84	-	1566.092
-	0	-	61.502)	/	467.949
=	1.06

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zhongyuan Union Cell & Gene Engineering's Days Inventory for the three months ended in Mar. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2025 )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
	=	234.517	/	111.146	*	365 / 4
	=	192.54

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zhongyuan Union Cell & Gene Engineering's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2025 )	/	Average Total Inventories (Q: Mar. 2025 )
	=	111.146	/	234.517
	=	0.47

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zhongyuan Union Cell & Gene Engineering's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	234.517	/	350.79
	=	0.67

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Zhongyuan Union Cell & Gene Engineering Total Inventories Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines